Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Daewoong Pharmaceutical
Daewoong Pharmaceutical
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
AffyXell expands partnership with GenScript ProBio
As part of the strategic alliance, GenScript has committed to take an equity position in AffyXell at a future funding round
Ingredients
Avacta expands South Korean partnership to include COVID-19 neutralising therapy
Avacta Group has expanded its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics
Ingredients
Affibody announces diabetes option exercise by Daewoong
Affibody will receive a license conversion fee and milestone payments as well as royalties. Further financial details were not disclosed.
Ingredients
Avacta, Daewoong and AffyXell to work on proteins for a range of targets
AffyCell has agreed to provide funds to Avacta for R&D costs of proteins produced by mesenchymal stem cells
Research & Development
Daewoong Pharmaceutical opens Chinese laboratory
Now established in Beijing and Shenyang
Subscribe now